Targeting of Ras-mediated FGF signaling suppresses Pten-deficient skin tumor

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2016-10-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.1604450113PMID 27799550PMCID PMC5135310
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction.

  2015cited by this paper
• Pten loss induces autocrine FGF signaling to promote skin tumorigenesis.

  2014cited by this paper
• Frs2&agr; and Shp2 signal independently of Gab to mediate FGF signaling in lens development

  2014cited by this paper
• Deficient FGF signaling causes optic nerve dysgenesis and ocular coloboma

  2013cited by this paper
• RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms

  2013cited by this paper
• Requirement for Interaction of PI3-Kinase p110α with RAS in Lung Tumor Maintenance

  2013cited by this paper
• An Allelic Series at the Paired Box Gene 6 (Pax6) Locus Reveals the Functional Specificity of Pax Genes*

  2013cited by this paper
• Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors.

  2013cited by this paper
• Spatially distinct roles of class Ia PI3K isoforms in the development and maintenance of PTEN hamartoma tumor syndrome.

  2013cited by this paper
• FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinoma.

  2013influential reference
• BRAF inhibitors in clinical oncology

  2013cited by this paper
• PTEN positively regulates UVB-induced DNA damage repair.

  2011cited by this paper
• c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma.

  2011cited by this paper
• Specific functions for ERK/MAPK signaling during PNS development.

  2011cited by this paper
• Loss of Shp2-Mediated Mitogen-Activated Protein Kinase Signaling in Müller Glial Cells Results in Retinal Degeneration

  2011cited by this paper
• Abstract 5287: Non-invasive imaging of tumor cell death using a Hsp90 ligand

  2011cited by this paper
• Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis.

  2011cited by this paper
• Raf family kinases: old dogs have learned new tricks.

  2011cited by this paper
• Raf-1 addiction in Ras-induced skin carcinogenesis.

  2009cited by this paper
• The FGF family: biology, pathophysiology and therapy

  2009cited by this paper
• Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development

  2008cited by this paper
• Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins

  2008cited by this paper
• Tenets of PTEN tumor suppression.

  2008cited by this paper
• PI3K pathway alterations in cancer: variations on a theme

  2008cited by this paper
• Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin.

  2008cited by this paper
• Generation of an Frs2alpha conditional null allele.

  2007cited by this paper
• Faculty Opinions recommendation of Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice.

  2007influential reference
• Raf kinase signaling functions in sensory neuron differentiation and axon growth in vivo

  2007cited by this paper
• Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice.

  2007cited by this paper
• The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development

  2007cited by this paper
• Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern

  2007cited by this paper
• PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.

  2006cited by this paper
• ERK and Beyond: Insights from B-Raf and Raf-1 Conditional Knockouts

  2006cited by this paper
• Generation of an Fgf9 conditional null allele

  2006cited by this paper
• Class IA Phosphoinositide 3-Kinase Regulates Heart Size and Physiological Cardiac Hypertrophy

  2005cited by this paper
• Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans.

  2005cited by this paper
• Deletion of Gab1 in the liver leads to enhanced glucose tolerance and improved hepatic insulin action

  2005cited by this paper
• Insights into regulation of human Schwann cell proliferation by Erk1/2 via a MEK-independent and p56Lck-dependent pathway from leprosy bacilli.

  2005cited by this paper
• Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression.

  2004cited by this paper
• Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism.

  2004cited by this paper
• Targets for molecular therapy of skin cancer.

  2004cited by this paper
• Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation.

  2003cited by this paper
• PTEN: One Gene, Many Syndromes

  2003cited by this paper
• Cre/loxP‐mediated inactivation of the murine Pten tumor suppressor gene

  2002cited by this paper
• Raf-1 Without MEK?

  2001cited by this paper
• Increased insulin sensitivity in mice lacking p85β subunit of phosphoinositide 3-kinase

  2001cited by this paper
• Negative regulation of the serine/threonine kinase B-Raf by Akt.

  2000cited by this paper
• Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye.

  2000cited by this paper
• Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt.

  1999cited by this paper
• Differential Regulation of Raf-1, A-Raf, and B-Raf by Oncogenic Ras and Tyrosine Kinases*

  1997influential reference
• Phosphatidylinositol-3-OH kinase direct target of Ras

  1994cited by this paper
• Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice.

  1993cited by this paper

• Formation of benign tumors by stem cell deregulation

  2022cites this paper
• Formation of Benign Tumours by Stem Cell Misregulation

  2022cites this paper
• Role of Tyrosine Kinase Receptors in Growth Factor Mediated Signal Transduction, with Specific Reference to MAPK/Rasand p13k-Akt Containing Pathways in Oncogenesis: A Qualitative Database Review

  2022cites this paper
• Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer

  2022cites this paper
• New developments in the biology of fibroblast growth factors.

  2022cites this paper
• FGF2 disruption enhances thermogenesis in brown and beige fat to protect against adiposity and hepatic steatosis

  2021cites this paper
• Lacrimal gland budding requires PI3K-dependent suppression of EGF signaling

  2021cites this paper
• The role of microRNAs in diseases and related signaling pathways

  2021cites this paper
• Design and Synthesis of Biotinylated Bivalent Carboline Derivatives as Potent Anti-tumor Agents.

  2020cites this paper
• Deciphering role of FGFR signalling pathway in pancreatic cancer

  2019cites this paper
• Leveraging Aberrant Iron Metabolism as a Method for Selective Drug Delivery and Imaging In Vivo

  2019cites this paper
• The Hippo pathway integrates PI3K–Akt signals with mechanical and polarity cues to control tissue growth

  2019cites this paper
• Fibroblast Growth Factor Receptor Signaling in Skin Cancers

  2019cites this paper